ライフサイエンスコーパス: best-corrected visual acuity

1 oroidal thickness [SFCT], phakic status, and best-corrected visual acuity.

2 d Early Treatment Diabetic Retinopathy Study best-corrected visual acuity.

3 jections (IVT), retinal detachment rate, and best-corrected visual acuity.

4 A significant difference was found in best-corrected visual acuity (0.01 logarithm of the mini

5 set (aged </=3 years) visual loss (mean [SD] best-corrected visual acuity, +0.95 [0.34] logMAR [20/18

6 r incidence of 15-letter or more decrease in best-corrected visual acuity (14% vs. 31%), and reduced

7 tained: subjective and objective refraction, best-corrected visual acuity, accommodation, contrast se

8 Final best-corrected visual acuity after chronic central serou

9 Best-corrected visual acuity after Descemet's stripping

10 ary outcome measures were the mean change in best corrected visual acuity and adverse events.

11 Best-corrected visual acuity and central macular thickne

12 At 2 years, mean best-corrected visual acuity and central retinal thickne

13 primary outcomes included the mean change in best-corrected visual acuity and central retinal thickne

14 Best-corrected visual acuity and CFT were examined from

15 ure at 6 days, rate of re-epithelialization, best-corrected visual acuity and infiltrate and/or scar

16 Monocular best-corrected visual acuity and reading acuity together

17 They were analyzed according to final best-corrected visual acuity and retinal morphological p

18 ariate analysis, after adjusting for initial best-corrected visual acuity and the antimicrobial treat

19 ata collected included patient demographics, best-corrected visual acuity, and OCT features of vitreo

20 egression analyses adjusted for age, gender, best-corrected visual acuity, and test duration showed t

21 tening complications), nonpersistent loss of best-corrected visual acuity, and transient hypotony (re

22 d on assessment of new inflammatory lesions, best corrected visual acuity, anterior chamber cell grad

23 rameters were evaluated: severity of injury, best corrected visual acuity at admission and last follo

24 tive vitreous hemorrhage, and mean change in best-corrected visual acuity at 12 months.

25 e primary outcome was defined as a change in best-corrected visual acuity at 52 weeks with a linear m

26 Best-corrected visual acuity at baseline was 0.5+/-0.1 l

27 Best-corrected visual acuity at fluid resolution was not

28 vs. 1.7%; P = 0.03) and significantly worse best-corrected visual acuity at the 12-month follow-up (

29 The primary outcome measure was best-corrected visual acuity at the final visit.

30 -0.17, -0.04; beta: -0.04; P = .003), worse best-corrected visual acuity (B: 0.64; 95% CI: 0.38, 0.9

31 imary outcome measure was change in the mean best corrected visual acuity (BCVA) after nine months, s

32 Best corrected visual acuity (BCVA) and stereoacuity (St

33 ances of the applied IOP-lowering drugs, the best corrected visual acuity (BCVA) and the mean deviati

34 Best corrected visual acuity (BCVA) at 6 weeks follow-up

35 Mean distance Best corrected visual acuity (BCVA) at initial presentat

36 The progression of non-RRD resulted in best corrected visual acuity (BCVA) decrease from 0.8 to

37 er in the younger age group (p-value 0.209), best corrected visual acuity (BCVA) improved significant

38 analysis showed a significant improvement of best corrected visual acuity (BCVA) in the treated eye o

39 Intraocular pressure (IOP), best corrected visual acuity (BCVA) logMAR and number of

40 atients with eyelid injuries showed a median best corrected visual acuity (BCVA) of logMAR 0.0.

41 d with regard to symptoms, refractive error, best corrected visual acuity (BCVA) of logMAR, binocular

42 The primary outcome measure was change in best corrected visual acuity (BCVA) over time.

43 Preoperative best corrected visual acuity (BCVA) showed and improveme

44 Ophthalmic examination included best corrected visual acuity (BCVA) testing and multimod

45 Best corrected visual acuity (BCVA), central retinal thi

46 ration of uveitis, severity of inflammation, best corrected visual acuity (BCVA), cystoid macular ede

47 Preoperative characteristics, best corrected visual acuity (BCVA), mean absolute spher

48 in outcomes were mean pre- and postoperative best corrected visual acuity (BCVA), postoperative astig

49 preoperative, early postoperative and final best corrected visual acuity (BCVA), rate of complicatio

50 ove both central macular thickness (CMT) and best corrected visual acuity (BCVA).

51 (CMT on SD-OCT; mum) and the visual outcome (best corrected visual acuity (BCVA); logMAR), as follows

52 y associated with capsule complications were best-corrected visual acuity (BCVA) <=0.1 (decimal, adju

53 icantly lower FVA and VR QoL included, lower best-corrected visual acuity (BCVA) (P < .0001 for both

54 jects were >/=65 years, had wet AMD, and had best-corrected visual acuity (BCVA) 10/200 to 20/80 in t

55 owing: 5-letter or fewer gain from baseline, best-corrected visual acuity (BCVA) 20/40 or worse, and

56 Best-corrected visual acuity (BCVA) 6 months after surge

57 ibercept in a q8-week regimen with regard to best-corrected visual acuity (BCVA) and brolucizumab ach

58 cy end point of the study was mean change in best-corrected visual acuity (BCVA) and central foveal t

59 Best-corrected visual acuity (BCVA) and central retinal

60 To investigate the relationship between best-corrected visual acuity (BCVA) and central retinal

61 Mean (and mean average) change in best-corrected visual acuity (BCVA) and central subfield

62 EGF injections and improvement from baseline best-corrected visual acuity (BCVA) and central subfield

63 association of these features with baseline best-corrected visual acuity (BCVA) and change in BCVA a

64 re assessed, as were the predictors of final best-corrected visual acuity (BCVA) and change in BCVA.

65 on was matched to investigate differences in best-corrected visual acuity (BCVA) and compared the sur

66 y (QUS) to measure vitreous echodensity, and best-corrected visual acuity (BCVA) and contrast sensiti

67 Questionnaire (VFQ-39) and were tested with best-corrected visual acuity (BCVA) and CSF measurements

68 Best-corrected visual acuity (BCVA) and CST were measure

69 ithm of minimum angle of resolution (logMAR) best-corrected visual acuity (BCVA) and evolution of mor

70 Poor initial best-corrected visual acuity (BCVA) and foveal and optic

71 ubjects underwent eye examinations including best-corrected visual acuity (BCVA) and Heidelberg Spect

72 Allocation was stratified by best-corrected visual acuity (BCVA) and hospital.

73 Secondary outcome measures were best-corrected visual acuity (BCVA) and neovascularizati

74 ospective comparative-effectiveness study of best-corrected visual acuity (BCVA) and refractive error

75 nt ophthalmic examination with assessment of best-corrected visual acuity (BCVA) and retinal imaging,

76 Best-corrected visual acuity (BCVA) and spectral domain

77 iation maculopathy confirmed by a decline in best-corrected visual acuity (BCVA) and spectral-domain

78 The main outcomes measured were final best-corrected visual acuity (BCVA) and surgical complic

79 To estimate the yearly rate of change of best-corrected visual acuity (BCVA) and the risk of loss

80 ma (group D) presented with light perception best-corrected visual acuity (BCVA) and tractional retin

81 aseline and annual eye examinations included best-corrected visual acuity (BCVA) assessments, slit-la

82 categorized into 3 groups based on change in best-corrected visual acuity (BCVA) at 3 months (logMAR

83 The primary outcome was best-corrected visual acuity (BCVA) at 6 months follow-u

84 The main outcome measures were best-corrected visual acuity (BCVA) at final follow-up v

85 -domain optical coherence tomography and the best-corrected visual acuity (BCVA) at six months.

86 primary outcome was change in amblyopic eye best-corrected visual acuity (BCVA) at the 2-week visit.

87 rimary outcome measurement was the change in best-corrected visual acuity (BCVA) at the end of the fo

88 ogy of SJS/TEN, age at treatment milestones, best-corrected visual acuity (BCVA) at treatment milesto

89 The best-corrected visual acuity (BCVA) before and after sur

90 5 mum, and visual impairment from DME with a best-corrected visual acuity (BCVA) between 24 letters a

91 baseline retinal morphologic parameters and best-corrected visual acuity (BCVA) change (structure-fu

92 Primary measure was best-corrected visual acuity (BCVA) change from baseline

93 : 5 letters at a 1-sided alpha level 0.1) in best-corrected visual acuity (BCVA) change from baseline

94 Mean best-corrected visual acuity (BCVA) change from baseline

95 to first recurrence, number of recurrences, best-corrected visual acuity (BCVA) change from baseline

96 atients with prior anti-VEGF treatment, mean best-corrected visual acuity (BCVA) changes from baselin

97 Best-corrected visual acuity (BCVA) data, retinal imagin

98 3 and month 6 after treatment, and a better best-corrected visual acuity (BCVA) during the first thr

99 ons, including measurement of presenting and best-corrected visual acuity (BCVA) for distance using t

100 [95% confidence interval], P value) gain in best-corrected visual acuity (BCVA) from baseline at Mon

101 The primary endpoint is the mean change in best-corrected visual acuity (BCVA) from baseline to 24

102 Main outcomes were mean average change in best-corrected visual acuity (BCVA) from baseline to mon

103 ome was improvement of 15 or more letters in best-corrected visual acuity (BCVA) from baseline.

104 acuity with presenting correction (APC), and best-corrected visual acuity (BCVA) from each eye.

105 Mean best-corrected visual acuity (BCVA) gains in the 2q4, 2q

106 Best-corrected visual acuity (BCVA) improved by -0.89 lo

107 Mean preoperative best-corrected visual acuity (BCVA) improved from 0.53+/

108 Two weeks later best-corrected visual acuity (BCVA) improved up to 20/25

109 cataract surgery and the patients (%) with a best-corrected visual acuity (BCVA) improvement of >/=15

110 The best-corrected visual acuity (BCVA) improvement was 0.16

111 s to be shown using a margin of 5 letters in best-corrected visual acuity (BCVA) improvement.

112 retinal inner layers (DRIL) is predictive of best-corrected visual acuity (BCVA) in retinal vein occl

113 ntage of eyes with improvement from baseline best-corrected visual acuity (BCVA) letter score >/=15 a

114 Mean best-corrected visual acuity (BCVA) letter score change,

115 oroidal neovascularization in either eye and best-corrected visual acuity (BCVA) letter score of 49 l

116 njections, then retreatment guided by either best-corrected visual acuity (BCVA) loss (Group I) or BC

117 mplete ophthalmologic examination, including best-corrected visual acuity (BCVA) measurement on ETDRS

118 The primary outcome was 1-year gain in best-corrected visual acuity (BCVA) of >/=15 letters.

119 All had best-corrected visual acuity (BCVA) of 20/20, no dry eye

120 lusion criteria included presence of VMA and best-corrected visual acuity (BCVA) of 20/32 or worse in

121 o age-related macular degeneration (AMD) and best-corrected visual acuity (BCVA) of 20/80 to 20/800.

122 Patients were required to have a best-corrected visual acuity (BCVA) of 5 or more Early T

123 (range, 239-727 mum) and a mean preinjection best-corrected visual acuity (BCVA) of 63 approximated E

124 After DMEK surgery, the mean best-corrected visual acuity (BCVA) ranged from 20/21 to

125 nical visit after the loading phase, OCT and best-corrected visual acuity (BCVA) testing were perform

126 .7 +/- 16.4 years (range 14-66) and the mean best-corrected visual acuity (BCVA) was 0.1 +/- 0.2 logM

127 ry high-volume cataract surgeons; the median best-corrected visual acuity (BCVA) was 0.5 (decimal) co

128 Mean preoperative best-corrected visual acuity (BCVA) was 1.11+/-0.59 loga

129 The mean preoperative best-corrected visual acuity (BCVA) was 1.39+/-0.64 loga

130 nimum angle of resolution (logMAR) (Snellen) best-corrected visual acuity (BCVA) was 1.81+/-0.56 (20/

131 Mean preoperative best-corrected visual acuity (BCVA) was 20/2000 (2 logar

132 Median best-corrected visual acuity (BCVA) was 20/30 at present

133 ce between the median preoperative and final best-corrected visual acuity (BCVA) was assessed and the

134 Baseline best-corrected visual acuity (BCVA) was better in LCS co

135 Baseline best-corrected visual acuity (BCVA) was between 0.3 and

136 Best-corrected visual acuity (BCVA) was compared between

137 Mean change from baseline best-corrected visual acuity (BCVA) was determined at we

138 Best-corrected visual acuity (BCVA) was measured 30 to 9

139 by time-domain optical coherence tomography, best-corrected visual acuity (BCVA) was measured by Earl

140 , and spectral-domain OCT were conducted and best-corrected visual acuity (BCVA) was obtained at base

141 Best-corrected visual acuity (BCVA) was recorded preoper

142 Mean best-corrected visual acuity (BCVA) was stable; 3 implan

143 Lesion size assessments and best-corrected visual acuity (BCVA) were conducted at sc

144 Presenting visual acuity (PVA) and best-corrected visual acuity (BCVA) were measured using

145 Follow-up OCT imaging and monocular best-corrected visual acuity (BCVA) were performed for t

146 The mean change in best-corrected visual acuity (BCVA) with IVT-AFL from ba

147 Safety end points were best-corrected visual acuity (BCVA), adverse events (AEs

148 Furthermore, best-corrected visual acuity (BCVA), age, and retinal pi

149 The best-corrected visual acuity (BCVA), Amsler test, M-char

150 al uncorrected visual acuity (UCVA), decimal best-corrected visual acuity (BCVA), and average keratom

151 Intraocular inflammation, best-corrected visual acuity (BCVA), and corticosteroid-

152 uded >=20% improvement and resolution of ME, best-corrected visual acuity (BCVA), and intraocular pre

153 omain optical coherence tomography (SD-OCT), best-corrected visual acuity (BCVA), and microperimetry.

154 Evaluations at each time point included best-corrected visual acuity (BCVA), anterior and poster

155 ements included endothelial cell loss (ECL), best-corrected visual acuity (BCVA), central corneal thi

156 moglobin A1c (HbA1c), body mass index (BMI), best-corrected visual acuity (BCVA), central subfield th

157 This study assessed relationships between best-corrected visual acuity (BCVA), central subfield th

158 mologic examinations including assessment of best-corrected visual acuity (BCVA), contrast sensitivit

159 Main outcome measures were best-corrected visual acuity (BCVA), endothelial cell de

160 The main outcome measures were postoperative best-corrected visual acuity (BCVA), endothelial cell de

161 Main outcome measures were best-corrected visual acuity (BCVA), endothelial cell de

162 Main outcome measures were best-corrected visual acuity (BCVA), endothelial cell de

163 Review of charts and photographs comprised best-corrected visual acuity (BCVA), foveal center field

164 Best-corrected visual acuity (BCVA), foveal thickness, t

165 MainOutcome Measures: Clinical presentation, best-corrected visual acuity (BCVA), fundus abnormalitie

166 subdivided into classic stages and underwent best-corrected visual acuity (BCVA), fundus autofluoresc

167 ar hole (FTMH), mean change from baseline in best-corrected visual acuity (BCVA), incidence of vitrec

168 Change of best-corrected visual acuity (BCVA), intraocular pressur

169 ular comorbidities, ocular surgical history, best-corrected visual acuity (BCVA), intraocular pressur

170 ation, distance of GA lesion from the fovea, best-corrected visual acuity (BCVA), low-luminance BCVA,

171 Measurements of visual function included best-corrected visual acuity (BCVA), low-luminance visua

172 outcome measures were the rate of change in best-corrected visual acuity (BCVA), low-luminance visua

173 Best-corrected visual acuity (BCVA), macular sensitivity

174 Change in mean best-corrected visual acuity (BCVA), mean central retina

175 Best-corrected visual acuity (BCVA), moderate visual los

176 demographics, preoperative and postoperative best-corrected visual acuity (BCVA), nuclear density, ex

177 Secondary outcome measures were best-corrected visual acuity (BCVA), number of antiglauc

178 Outcome measurements were best-corrected visual acuity (BCVA), refractive astigmat

179 Improvement in best-corrected visual acuity (BCVA), resolution of subre

180 The parameters evaluated were the best-corrected visual acuity (BCVA), Schirmer test, tear

181 ratory efficacy measures included changes in best-corrected visual acuity (BCVA), static perimetry ce

182 Best-corrected visual acuity (BCVA), tear osmolarity, th

183 was assessed and correlated to the degree of best-corrected visual acuity (BCVA).

184 erative complications, device retention, and best-corrected visual acuity (BCVA).

185 radiation retinopathy, optic neuropathy, and best-corrected visual acuity (BCVA).

186 Ocular surface stability, best-corrected visual acuity (BCVA).

187 al severity scale, vascular clock hours, and best-corrected visual acuity (BCVA).

188 OCTA contributed significantly to diminished best-corrected visual acuity (BCVA).

189 The objective tests were scores for best-corrected visual acuity (BCVA); using the LogMAR sc

190 All groups demonstrated improved best-corrected visual acuity (BCVA; average, 0.46 logari

191 near and distant activities subscale scores, best-corrected visual acuity (BCVA; Early Treatment Diab

192 Eyes with predominantly classic CNV (mean best-corrected visual acuity [BCVA], 48.2 letters at bas

193 Main outcome parameters (survival, best-corrected visual acuity [BCVA], central endothelial

194 arameters, postvitrectomy complications, and best-corrected visual acuities (BCVAs) were identified.

195 detachment (SRD) with single PDT, change in best-corrected visual acuities (BCVAs), and recurrence r

196 Black on White Best Corrected Visual Acuity (BW-BCVA), White on Black B

197 Main outcome measures included best-corrected visual acuity, central retinal thickness,

198 cuity response (mean change from baseline in best-corrected visual acuity [CFB BCVA]; categorized imp

199 The primary outcome was best-corrected visual acuity change (DeltaBCVA, logarith

200 Best-corrected visual acuity changed by -0.2 letters in

201 s underwent a baseline examination including best-corrected visual acuity, color photos, optical cohe

202 mologic examinations included cover testing, best corrected visual acuity, cycloplegic objective refr

203 The mean best-corrected visual acuity declined by 2 lines post-PE

204 Best-corrected visual acuity decreased from 20/25 to 20/

205 duration of diabetes, source of referral and best-corrected visual acuity, diabetic retinopathy statu

206 Baseline best-corrected visual acuity differed between these grou

207 modified intention-to-treat population (mean best corrected visual acuity difference 3.9 letters [95%

208 Because best-corrected visual acuity does not correspond directl

209 ere was a significant increase (P < .001) in best-corrected visual acuity from a letter score of 63.3

210 There was a significant improvement in best-corrected visual acuity from a mean of 0.65 LogMAR

211 endpoints were the change in mean and median best-corrected visual acuity from baseline at years 1 an

212 The eye with the worst best-corrected visual acuity from each patient was selec

213 symptoms and the results of ophthalmoscopy, best-corrected visual acuity, full-field electroretinogr

214 Best-corrected visual acuity, fundus photographs, and sp

215 horoidal thickness) for functional response (best-corrected visual acuity gain >/=2 lines) were asses

216 The mean best-corrected visual acuity gain from baseline to week

217 met its main objective, demonstrating a mean best-corrected visual acuity gain of 8.3 letters (mean 6

218 Best-corrected visual acuity gains achieved during VISTA

219 A subgroup of PRN patients were analyzed for best-corrected visual acuity gains at 24 months.

220 Mean best-corrected visual acuity gains from baseline with Rq

221 In seven cases, the mean best-corrected visual acuity improved after foveal reatt

222 n unaided visual acuity was 6/12 (20/40) and best-corrected visual acuity improved from 6/20 (20/63)

223 Following the first implantation, average best-corrected visual acuity improved significantly from

224 Significant best-corrected visual acuity improvement was associated

225 Best-corrected visual acuity in logarithm of minimum ang

226 million people in the United States had VI (best-corrected visual acuity in the better-seeing eye),

227 Primary outcome was change from baseline in best-corrected visual acuity in uveitic eyes (5 letters

228 up, including preoperative and postoperative best-corrected visual acuity, incidence of macular edema

229 Best-corrected visual acuity, Indian Vision Function Que

230 All patients had preserved best-corrected visual acuity into adulthood, with a mean

231 an exhaustive ophthalmological examination (best-corrected visual acuity, intraocular pressure, biom

232 Patients with decreased best corrected visual acuity, Khodadoust line, and anter

233 Best-corrected visual acuity letter score gain of 15 let

234 Median BCVA (best-corrected visual acuity, logMAR) was 0.1 in the MFS

235 The main outcome measures were best-corrected visual acuity, long-term ocular sequelae,

236 risk factors associated with SVI (best-corrected visual acuity <20/200) and vision-threate

237 His best corrected visual acuity markedly improved from 20/5

238 Postoperative mean best-corrected visual acuity measured 0.14+/-0.26 logari

239 Median best-corrected visual acuity measured 20/63 (range, 20/2

240 Every 4 weeks, participants underwent best-corrected visual acuity measurement, fundus examina

241 als aged 3 years or older with, in each eye, best corrected visual acuity of 20/60 or worse, or visua

242 nts with open globe injuries showed a median best corrected visual acuity of logMAR 1.5 at admission,

243 t had experienced at least 1 RD, achieving a best-corrected visual acuity of >/=20/40 compared to 53%

244 Final best-corrected visual acuity of >20/200 was achieved in

245 and a half times more likely to have a final best-corrected visual acuity of <20/60 compared to those

246 ision, with the exception of 3 patients with best-corrected visual acuity of 0.8 (Snellen).

247 from 11 to 89 years of age, with a baseline best-corrected visual acuity of 2.3 to -0.2 logarithm of

248 among 12 patients with visual impairment and best-corrected visual acuity of 20/200 or worse in their

249 last follow-up, 6 of 19 patients (31.6%) had best-corrected visual acuity of 20/400 or better.

250 patient age was 34.2 (14.7) years, mean (SD) best-corrected visual acuity of all eyes was 47.8 (16.9)

251 nd 11 eyes with low MS (<6 dB) but very good best-corrected visual acuity of at least 72 Early Treatm

252 Postoperative best-corrected visual acuity of the study group was wors

253 at onset, medical history, initial symptoms, best-corrected visual acuity, ophthalmoscopy, fundus pho

254 of pattern-reversal visual evoked potential, best-corrected visual acuity, optic nerve appearance, vi

255 months; >98% of all subjects achieved 20/40 best-corrected visual acuity or better.

256 th factor without significant improvement of best-corrected visual acuity or macular edema.

257 differences in the postoperative unaided or best-corrected visual acuity, or in the numbers of patie

258 nd 52 weeks, having excluded fluctuations in best corrected visual acuity owing to vitreous haemorrha

259 ), significantly worse visual functions were best-corrected visual acuity (P = 0.0444), low-luminance

260 ns, cycloplegic refractions, uncorrected and best-corrected visual acuities, power vector of astigmat

261 ensity in the SRL negatively correlated with best-corrected visual acuity (r = -0.28; P = .05) and se

262 reoperative and postoperative data including best corrected visual acuity recorded in LogMAR units, s

263 Best-corrected visual acuity recorded before surgery ran

264 Best-corrected visual acuity remained stable in both gro

265 -related macular degeneration and a baseline best-corrected visual acuity score of 20/100 or less in

266 prehensive ophthalmic examination, including best-corrected visual acuity, slit-lamp biomicroscopy, a

267 Best-corrected visual acuity, slit-lamp biomicroscopy, d

268 amination, including medical history review, best-corrected visual acuity, slitlamp biomicroscopy, in

269 Ophthalmic history, best-corrected visual acuity, spectral-domain OCT result

270 Ophthalmic assessment included best-corrected visual acuity testing, electrophysiologic

271 improved from a mean (SD) of 2.5 (1.6) using best-corrected visual acuity to 9.5 (0.5) using the port

272 d RIDE/RISE, the proportion of patients with best-corrected visual acuity typically required for an u

273 We assessed preoperative best-corrected visual acuity; ultrasound central corneal

274 All patients routinely underwent Snellen best-corrected visual acuity (VA) measurement, CFP, spec

275 The mean +/- SD of the best-corrected visual acuity (VA) was 0.960 +/- 0.086 de

276 Best-corrected visual acuity (VA), complications, resolu

277 ristics of the RRD, surgical procedures, and best-corrected visual acuity (VA).

278 atment of Diabetic Retinopathy Study (ETDRS) best-corrected visual acuity (VA).

279 Vision tests probed cones (best-corrected visual acuity [VA], contrast sensitivity)

280 Best-corrected visual acuity, visual fields, and OCT ret

281 Median best-corrected visual acuity was 0.20 logarithm of the m

282 Mean best-corrected visual acuity was 0.74 +/- 0.39 logarithm

283 Upon examination, best-corrected visual acuity was 20/100 in the right eye

284 On examination, best-corrected visual acuity was 20/20 in both eyes.

285 Best-corrected visual acuity was 20/50 or worse in 37.3%

286 r most GSS and NEI-VFQ-25 items, while lower best-corrected visual acuity was associated with lower s

287 One-year postoperative best-corrected visual acuity was comparable (P = 0.09).

288 entage of patients achieving 20/40 or better best-corrected visual acuity was higher in the DMEK grou

289 Best-corrected visual acuity was improved in 13 eyes (81

290 Best-corrected visual acuity was measured using the Earl

291 Best-corrected visual acuity was severely reduced to res

292 Preoperative best-corrected visual acuity was significantly better in

293 over the entire follow-up period (P < .001); best-corrected visual acuity was similar at every time p

294 cted Visual Acuity (BW-BCVA), White on Black Best Corrected Visual Acuity (WB-BCVA), Mars Contrast Se

295 accommodation amplitude, pupil diameter, and best-corrected visual acuity were measured at baseline,

296 At 1 year, >/=10- and >/=15-letter gains in best-corrected visual acuity were observed in 34.5% (10/

297 change in vitreous haze grade, and change in best corrected visual acuity) were significantly better

298 s' functionality in 3 scenarios: using their best-corrected visual acuity with no low-vision aids, us

299 Changes in best-corrected visual acuity with RTH258 were comparable

300 The prevalence of visual impairment (best-corrected visual acuity worse than 20/40 in the bet